P8A logo

Cordlife Group Limited Stock Price

SGX:P8A Community·S$44.6m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

P8A Share Price Performance

S$0.17
0.00 (2.35%)
S$0.17
0.00 (2.35%)
Price S$0.17

P8A Community Narratives

There are no narratives available yet.

Recent P8A News & Updates

Revenues Working Against Cordlife Group Limited's (SGX:P8A) Share Price Following 25% Dive

Oct 08
Revenues Working Against Cordlife Group Limited's (SGX:P8A) Share Price Following 25% Dive

Optimistic Investors Push Cordlife Group Limited (SGX:P8A) Shares Up 66% But Growth Is Lacking

May 20
Optimistic Investors Push Cordlife Group Limited (SGX:P8A) Shares Up 66% But Growth Is Lacking

Risks To Shareholder Returns Are Elevated At These Prices For Cordlife Group Limited (SGX:P8A)

Jan 21
Risks To Shareholder Returns Are Elevated At These Prices For Cordlife Group Limited (SGX:P8A)

Cordlife Group Limited Key Details

S$37.6m

Revenue

S$16.6m

Cost of Revenue

S$21.1m

Gross Profit

S$32.2m

Other Expenses

-S$11.1m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
-0.043
Gross Margin
56.00%
Net Profit Margin
-29.57%
Debt/Equity Ratio
0%

Cordlife Group Limited Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Flawless balance sheet with low risk.

3 Risks
0 Rewards

About P8A

Founded
2001
Employees
n/a
CEO
Xiaoling Chen
WebsiteView website
www.cordlife.com

Cordlife Group Limited, an investment holding company, provides cord blood banking services in Singapore, Hong Kong, India, Malaysia, the Philippines, and internationally. It operates in two segments, Banking and Diagnostics. The Banking segment collects, processes, banks, and tests biological materials, such as cord blood, lining, and tissue samples. The Diagnostics segment offers diagnostic testing services, such as newborn genetic and metabolic screenings; pediatric vision and ear screenings; pediatric allergen test; and genetic talent test services. The company also provides corneal lenticule banking, gut microbiome banking, and lifestyle genetic screening services for adults. In addition, it offers Moms Up, a mobile application that offers parenting resources, as well as sprouts for health, wellness, and lifestyle needs. Further, the company provides medical laboratory, marketing, and property investment services, as well as medical and pharmaceutical research and development and consulting services. Cordlife Group Limited was incorporated in 2001 and is based in Singapore.

Market Insight

Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading

Singaporean Market Performance

  • 7 Days: -0.6%
  • 3 Months: 7.2%
  • 1 Year: 20.6%
  • Year to Date: 17.0%
Over the last 7 days, the market has remained flat, although notably the Healthcare sector gained 3.3% in that time. Meanwhile, the market is actually up 21% over the past year. Earnings are forecast to grow by 6.6% annually. Market details ›